Nomogram for predicting the prognosis of metastatic colorectal cancer patients treated with anti-PD1 therapy based on serum lipids analysis

BACKGROUND: Serum lipids have been identified to be used as prognostic biomarkers in several types of cancer. The primary objective of this study was to evaluate the prognostic value of serum lipids in metastatic colorectal cancer (mCRC) patients received anti-PD-1 therapy. METHODS: Pretreatment and...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Bijing, Ouyang, Hui, Gulizeba, Haimiti, Fu, Haiyan, Wang, Zhiqiang, Huang, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576722/
https://www.ncbi.nlm.nih.gov/pubmed/37589756
http://dx.doi.org/10.1007/s00262-023-03519-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576722/
https://www.ncbi.nlm.nih.gov/pubmed/37589756
http://dx.doi.org/10.1007/s00262-023-03519-y

Ejemplares similares